VGTI Florida Announces New Director of Business Development
Published: Dec 05, 2012
PORT ST. LUCIE, Fla.--(BUSINESS WIRE)--The Vaccine and Gene Therapy Institute of Florida (VGTI Florida) is pleased to announce the appointment of Catherine E. Vorwald to Director, Business Development. “We dedicate ourselves every single day to finding novel treatments for chronic diseases like cancer and HIV/AIDS,” said Mel Rothberg, Chief Operating Officer, VGTI Florida. “We’re pleased to have Catherine onboard. By leading our business development efforts, she will facilitate the commercial translation of therapeutic discoveries so that patients around the world will ultimately be better served and suffer less,” he continued.